Omalizumab?

Omalizumab is a humanized monoclonal antibody that targets immunoglobulin E (IgE). It’s sold under the brand name Xolair (and in some places as a biosimilar). It’s not a quick-acting rescue medicine; it’s used for long-term control of allergic conditions.

Key points:
- What it’s used for
- Moderate-to-severe persistent allergic asthma in patients aged typically 6 years and older (with positive IgE tests and inadequately controlled on inhaled corticosteroids).
- Chronic spontaneous (idiopathic) urticaria in adults and adolescents 12 years and older who remain symptomatic despite antihistamines.
- Other uses in certain allergic conditions may be considered off-label; your clinician can advise.
- How it works
- It binds to free IgE, reducing IgE’s ability to activate mast cells and basophils. This lowers the allergic response and helps reduce asthma symptoms and urticaria flares.
- How it’s given
- Administered by a healthcare professional as a subcutaneous injection. Some patients may be trained to self-inject at home after a period of supervised administration.
- First doses are typically given in a clinic with observation afterward due to the small risk of anaphylaxis.
- Dosing basics
- Dosing is individualized.
- For asthma: dose depends on body weight and baseline IgE level; given every 2 or every 4 weeks.
- For chronic urticaria: dosing is generally either 150 mg or 300 mg every 4 weeks (adjusted based on response and clinician judgment).
- Because dosing is based on specific tests and patient factors, your clinician will provide the exact dose and schedule.
- Safety and monitoring
- Boxed warning for anaphylaxis: can occur, most often within the first several injections. Patients should be observed after injections (often for 2 hours after the first few doses).
- Common side effects: injection-site reactions, headaches, cold symptoms, and upper respiratory infections.
- Serious but rare: anaphylaxis, cardiovascular events (rare), and potential interactions with other medications are generally not a concern, but discuss all medicines you take.
- Contraindications include a known allergy to omalizumab or any of its components.
- Practical notes
- Storage: refrigerate (2-8°C); protect from light; do not shake; allow to reach room temperature before injecting if instructed.
- Not for immediate relief of an asthma attack or hives; it’s a long-term therapy.
- Pregnancy: handled on a case-by-case basis; discuss with your clinician.

If you’d like, tell me whether you’re asking about asthma, chronic urticaria, dosing specifics, safety, or how it compares to other therapies. I can tailor the information to your situation or provide dosing examples.